EUVIMEDEUVIMED entdecken
Crossref

26-A-15662-ACC TRENDS IN UTILIZATION, SPENDING, AND COVERAGE FOR PCSK9 INHIBITORS IN MEDICARE PART D

Jalpa Doshi, Matthew Klebanoff, Maya Merchant, Pengxiang Li, Dhruv Kazi

JACC · 2026-04 · 87 (13) · A316

DOI: 10.1016/j.jacc.2026.02.783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Jalpa Doshi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Doshi, J., Klebanoff, M., Merchant, M., Li, P., & Kazi, D. (2026). 26-A-15662-ACC TRENDS IN UTILIZATION, SPENDING, AND COVERAGE FOR PCSK9 INHIBITORS IN MEDICARE PART D. JACC, 87(13), A316. https://doi.org/10.1016/j.jacc.2026.02.783

Vancouver

Doshi J, Klebanoff M, Merchant M, Li P, Kazi D. 26-A-15662-ACC TRENDS IN UTILIZATION, SPENDING, AND COVERAGE FOR PCSK9 INHIBITORS IN MEDICARE PART D. JACC. 2026;87(13):A316. doi:10.1016/j.jacc.2026.02.783

BibTeX
@article{Doshi2026,
  author = {Doshi, Jalpa and Klebanoff, Matthew and Merchant, Maya and Li, Pengxiang and Kazi, Dhruv},
  title = {26-A-15662-ACC TRENDS IN UTILIZATION, SPENDING, AND COVERAGE FOR PCSK9 INHIBITORS IN MEDICARE PART D},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A316},
  doi = {10.1016/j.jacc.2026.02.783}
}
Kostenlos starten →